|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 31/4196 | (2006.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 1455781 |
| (13) | Kind of document | T |
| (96) | European patent application number | 02783305.2 |
| Date of filing the European patent application | 2002-12-06 | |
| (97) | Date of publication of the European application | 2004-09-15 |
| (45) | Date of publication and mention of the grant of the patent | 2008-08-27 |
| (46) | Date of publication of the claims translation | 2008-11-25 |
| (86) | Number | PCT/GB2002/005554 |
| Date | 2002-12-06 |
| (87) | Number | WO 2003/053438 |
| Date | 2003-07-03 |
| (30) | Number | Date | Country code |
| 0129457 | 2001-12-10 | GB |
| (72) |
PLOURDE, Paul, US
ROGERS, Anthony, US
VOSE, Brent, GB
DUKES, Michael, GB
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Anastrozolo panaudojimas postmenopauzės amžiaus moterų, sergančių ankstyvos stadijos krūties vėžiu, gydymui |
| USE OF ANASTROZOLE FOR THE TREATMENT OF POST-MENOPAUSAL WOMEN HAVING EARLY BREAST CANCER |
| Payment date | Validity (years) | Amount | |
| 2014-11-20 | 13 | 1000.00 LTL |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2015-06-03 |